This invention provides O-&agr;-acyloxyalkyl ethers of the venlafaxine metabolite 4-[2-(Dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol, represented by Formula (I):
wherein:
the configuration at the steriogenic center (*) may be R, S, or RS (the racemate);
wherein radicals R1, R2, R3, R4, and R5 are as defined in the specification; as well as pharmaceutical compositions and methods treating central nervous system disorders.
这项发明提供了
文拉法辛代谢物4-[2-(二甲基
氨基-1-(1-羟基环己基)乙基]
苯酚的O-α-酰氧烷基醚,用
化学式(I)表示:其中:立体异构中心(*)的构型可以是R、S或RS(消旋体);其中基团R1、R2、R3、R4和R5如规范中所定义;以及治疗中枢神经系统疾病的药物组合物和方法。